SS, L., HY, L., TM, C., YS, S., & JF, L. (2026). FGF2 as a Potential Tumor Suppressor in Lung Adenocarcinoma. Diagnostics (Basel, Switzerland), 16(2), . https://doi.org/10.3390/diagnostics16020250
Chicago Style (17th ed.) CitationSS, Lin, Lu HY, Chang TM, Sun YS, and Liu JF. "FGF2 as a Potential Tumor Suppressor in Lung Adenocarcinoma." Diagnostics (Basel, Switzerland) 16, no. 2 (2026). https://doi.org/10.3390/diagnostics16020250.
MLA (9th ed.) CitationSS, Lin, et al. "FGF2 as a Potential Tumor Suppressor in Lung Adenocarcinoma." Diagnostics (Basel, Switzerland), vol. 16, no. 2, 2026, https://doi.org/10.3390/diagnostics16020250.
Warning: These citations may not always be 100% accurate.